0001562180-20-006793.txt : 20201119
0001562180-20-006793.hdr.sgml : 20201119
20201119122748
ACCESSION NUMBER: 0001562180-20-006793
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201109
FILED AS OF DATE: 20201119
DATE AS OF CHANGE: 20201119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seth Alpna
CENTRAL INDEX KEY: 0001721020
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 201327967
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-11-09
false
0000842023
BIO-TECHNE Corp
TECH
0001721020
Seth Alpna
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
true
false
false
false
Common Stock
2020-11-09
4
M
false
1898.00
179.84
A
4037.00
D
Common Stock
2020-11-09
4
M
false
3125.00
125.05
A
7162.00
D
Common Stock
2020-11-09
4
S
false
1358.00
305.74
D
5804.00
D
Common Stock
2020-11-09
4
S
false
3665.00
306.95
D
2139.00
D
Stock Option (Right to Buy)
179.84
2020-11-09
4
M
false
1898.00
0.00
D
2028-10-25
Common Stock
1898.00
0.00
D
Stock Option (Right to Buy)
125.05
2020-11-09
4
M
false
3125.00
0.00
D
2027-10-26
Common Stock
3125.00
0.00
D
Stock Option (Right to Buy)
255.69
2021-10-29
2030-10-29
Common Stock
1507.00
1507.00
D
Stock Option (Right to Buy)
201.64
2020-10-24
2029-10-24
Common Stock
2011.00
2011.00
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.72 to $305.79, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.84 to $307.26, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Fully exercisable
/s/ Brenda S. Furlow, attorney in fact for Seth Alpna pursuant to Power of Attorney previously filed
2020-11-12
EX-24
2
sethpoa2017.txt
SETHPOA2017
POWER OF ATTORNEY
The undersigned hereby constitutes and
appoints Brenda S. Furlow, James Hippel, Anna
Weispfenning, Melodie R. Rose, Andrew Nick,
Sarah Tucher or either of them acting alone,
the undersigned's true and lawful attorneys-
in-fact and agent with full power of
substitution and resubstitution, for the
undersigned and in the undersigned's name,
place and stead, in any and all capacities,
to sign any or all Forms 3, Forms 4 and
Forms 5 relating to beneficial ownership of
securities of Bio-Techne Corporation (the
"Issuer"), to file the same, with all
exhibits thereto and other documents in
connection therewith, with the Securities and
Exchange Commission and to deliver a copy of
the same to the Issuer, granting unto said
attorney-in-fact and agent full power and
authority to do and perform each and every
act and thing requisite and necessary to be
done in and about the premises, as fully to
all intents and purposes as the undersigned
might or could do in person, hereby ratifying
and confirming all said attorneys-in-fact and
agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue
thereof. The undersigned acknowledges that
the foregoing attorney-in-fact, in serving in
such capacity at the request of the
undersigned, is not assuming any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of
1934.
This Power of Attorney shall remain in
effect until such time as the undersigned is
no longer subject to the provisions of
Section 16 of the Securities Exchange Act of
1934 with respect to securities of the
Issuer.
IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed
as of this 26th day of October, 2017.
/s/ Alpna Seth